Concurrent Session 5B: Abstract Session - Exploring unresolved challenges: issues for further attention
Tracks
.
| Saturday, August 3, 2024 |
| 11:45 AM - 12:45 PM |
| Betbiyan 3 & Bundirrik 4 |
Speaker
VH2024 Conference
Welcome & Introduction
11:45 AM - 11:50 AMBiography
Dr. Evan Cunningham
Research Fellow, Viral Hepatitis and Clinical Research Program
Kirby Institute
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people who inject drugs: the sharp-c study
11:50 AM - 12:05 PMBiography
Evan is a research fellow at the Kirby Institute in Sydney whose research focusses on addressing the remaining barriers to HCV elimination.
Dr Laura McCoullough
Medical Scientist
Victorian Infectious Diseases Reference Laboratory
Suppression of hepatitis B virus replication and surface antigen using CRISPR-Cas13b – pre-clinical investigations of a new therapeutic approach
12:05 PM - 12:20 PMBiography
Laura is a Medical Scientist at the Victorian Infectious Diseases Reference Laboratory in Melbourne. She has recently completed her PhD where she optimised the CRISPR-Cas13b system to target hepatitis B RNAs to reduce HBV replication as a potential novel therapy for HBV.
Dr Chris Seaman
Research Officer
Burnet Institute
Benefits of hepatitis B treatment in Australia: health and economic impacts of nucleos(t)ide analogues (NUCs)
12:20 PM - 12:35 PMBiography
Chris is a postdoctoral mathematical modeller working at the Burnet Institute. His primary research focus is the use of mathematical models to eliminate hepatitis B as a public health threat.
Mr Rodney Guzman
Research Nurse
Burnet Institute
Evaluating performance of rapid point-of-care antibody testing for hepatitis C
12:35 PM - 12:40 PMBiography
Rodney Guzman is a clinical research nurse with a ten-year career spanning surgical nursing, neuroscience research and community health.
Mr Shane Tillakeratne
Data Manager, Phd Student
Kirby Institute
Progress towards viral hepatitis elimination mortality targets in New South Wales, Australia
12:40 PM - 12:45 PMBiography
Shane Tillakeratne is a PhD student and data manager working on evaluating viral hepatitis treatments for marginalized communities in Australia, utilising various health records and information to better understand if treatments are reaching and effectively helping those who need them most.
Chairperson
Nicole Allard
Researcher
WHO Collaborating Centre For Viral Hepatitis
Danielle Esler
Deputy Chief Health Officer
Northern Territory Department Of Health
